Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Duration in Recurrent Implantation Failure
NCT03504345Unknown
- Sponsor
- Mount Sinai Hospital
- Start
- May 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
01
Overview
Randomised trial of progesterone in Recurrent Implantation Failure (RIF) (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Clinical Pregnancy Rate. Status: unknown.
02
Drugs
progesterone
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03504345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03504345.